TransMedics Group Inc (TMDX)

Cash ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents US$ in thousands 394,812 201,182 25,580 24,581 20,092
Short-term investments US$ in thousands 66,920 101,019 60,608
Total current liabilities US$ in thousands 54,934 23,661 23,238 11,879 16,115
Cash ratio 7.19 8.50 3.98 10.57 5.01

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($394,812K + $—K) ÷ $54,934K
= 7.19

The cash ratio of TransMedics Group Inc has exhibited variation in recent years, ranging from 3.98 to 10.57. In 2023, the cash ratio decreased to 7.19 from 8.50 in 2022, indicating a decline in the company's ability to cover its short-term liabilities solely with its available cash and cash equivalents. However, the ratio remains relatively healthy, suggesting that the company still possesses a significant amount of liquid assets compared to its current liabilities. Further analysis would be needed to understand the factors contributing to this trend and evaluate the overall liquidity position of TransMedics Group Inc.


Peer comparison

Dec 31, 2023